Crocs, Inc. (CROX): Hedge Funds Aren’t Crazy About It, Insider Sentiment Unchanged

Page 1 of 2

Now, according to many investors, hedge funds are seen as useless, old financial tools of a forgotten age. Although there are over 8,000 hedge funds in operation in present day, this site looks at the moguls of this club, close to 525 funds. It is assumed that this group controls the lion’s share of all hedge funds’ total assets, and by tracking their highest quality equity investments, we’ve uncovered a few investment strategies that have historically outstripped the broader indices. Our small-cap hedge fund strategy outpaced the S&P 500 index by 18 percentage points per annum for a decade in our back tests, and since we’ve started sharing our picks with our subscribers at the end of August 2012, we have topped the S&P 500 index by 33 percentage points in 11 months (see all of our picks from August).

Just as useful, bullish insider trading activity is a second way to look at the marketplace. Just as you’d expect, there are a number of stimuli for an executive to downsize shares of his or her company, but just one, very clear reason why they would behave bullishly. Plenty of academic studies have demonstrated the valuable potential of this strategy if piggybackers understand where to look (learn more here).

Furthermore, we’re going to discuss the recent info about Crocs, Inc. (NASDAQ:CROX).

Crocs, Inc. (NASDAQ:CROX)

How have hedgies been trading Crocs, Inc. (NASDAQ:CROX)?

In preparation for the third quarter, a total of 20 of the hedge funds we track were bullish in this stock, a change of -23% from one quarter earlier. With hedge funds’ positions undergoing their usual ebb and flow, there exists a select group of notable hedge fund managers who were boosting their stakes meaningfully.

When using filings from the hedgies we track, Royce & Associates, managed by Chuck Royce, holds the biggest position in Crocs, Inc. (NASDAQ:CROX). Royce & Associates has a $83.9 million position in the stock, comprising 0.3% of its 13F portfolio. The second largest stake is held by Daruma Asset Management, managed by Mariko Gordon, which held a $69.4 million position; the fund has 3.4% of its 13F portfolio invested in the stock. Some other hedgies that hold long positions include Leon Cooperman’s Omega Advisors, Cliff Asness’s AQR Capital Management and Sanford J. Colen’s Apex Capital.

As Crocs, Inc. (NASDAQ:CROX) has faced a fall in interest from the top-tier hedge fund industry, it’s safe to say that there was a specific group of hedge funds that slashed their entire stakes last quarter. Interestingly, David Keidan’s Buckingham Capital Management said goodbye to the largest position of all the hedgies we key on, worth about $9.7 million in stock, and Jim Simons of Renaissance Technologies was right behind this move, as the fund sold off about $3.7 million worth. These transactions are interesting, as total hedge fund interest was cut by 6 funds last quarter.

What do corporate executives and insiders think about Crocs, Inc. (NASDAQ:CROX)?

Insider buying is particularly usable when the primary stock in question has experienced transactions within the past six months. Over the latest 180-day time period, Crocs, Inc. (NASDAQ:CROX) has seen zero unique insiders buying, and zero insider sales (see the details of insider trades here).

We’ll also review the relationship between both of these indicators in other stocks similar to Crocs, Inc. (NASDAQ:CROX). These stocks are Steven Madden, Ltd. (NASDAQ:SHOO), Vera Bradley, Inc. (NASDAQ:VRA), Iconix Brand Group Inc (NASDAQ:ICON), Skechers USA Inc (NYSE:SKX), and Tumi Holdings Inc (NYSE:TUMI). This group of stocks belong to the textile – apparel footwear & accessories industry and their market caps are similar to CROX’s market cap.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!